Guidelines for the care and treatment of patients with central serous chorioretinopathy

Central serous chorioretinopathy is an acute exudative disease of the macula, which affects primarily young males, but can also be found in pregnant or postmenopausal females. In most cases there is a spontaneous resorption of acute exudation, which could be further improved by offering specific information to the patient. If the exudation persists longer than 3 months, a photodynamic treatment with reduced laser fluence or half dose of Verteporfin should be offered to the patient. The prescription of other medications should be avoided, since there are no medications with proved efficacy available. Using medication of any kind might also hinder an efficient change of life style, which seems to be the most effective treatment for many cases.